- Investing Ideas
- /
- Australian Pharmaceuticals & Biotech Buy the Dip
Australian Pharmaceuticals & Biotech Buy the Dip
Results
2
2 new
Companies which have seen a dip in the last 7 days after continued gains and are looking undervalued based on Snowflake checks.
2 companies
Paradigm Biopharmaceuticals
Market Cap: AU$141.4m
Paradigm Biopharmaceuticals Limited se dedica a la investigación y desarrollo de productos terapéuticos para uso humano en Australia.
New
PAR
AU$0.33
7D
-15.4%
1Y
34.7%
NeuroScientific Biopharmaceuticals
Market Cap: AU$38.2m
NeuroScientific Biopharmaceuticals Limited se dedica a la investigación y desarrollo de nuevos productos farmacéuticos basados en péptidos.
New
NSB
AU$0.12
7D
-14.8%
1Y
219.4%